Rick Baehner, MD
Professor
Pathology
School of Medicine

Publications (99)

Top publication keywords:
Antineoplastic Combined Chemotherapy ProtocolsBreast NeoplasmsReceptors, EstrogenLymph NodesBiomarkers, TumorTrastuzumabCarcinoma, Intraductal, NoninfiltratingAntineoplastic Agents, HormonalTamoxifenLymphocytes, Tumor-InfiltratingGene Expression ProfilingNeoplasm Recurrence, LocalMastectomy, SegmentalReverse Transcriptase Polymerase Chain ReactionNorovirus

• Refining Risk Assessment for Adjuvant CDK4/6 Inhibitors beyond Trial Inclusion Criteria: Integrating Recurrence Score and Endocrine Responsiveness according to ADAPT.
  Breast care (Basel, Switzerland) 2026 Braun M, Gluz O, Kuemmel S, Nitz U, Luedtke-Heckenkamp K, Darsow M, Forstbauer H, Polata S, Grischke EM, Uleer C, Aktas B, Schumacher C, Zu Eulenburg C, Kates R, Burmeister S, Graeser M, Wuerstlein R,…
• Cognitive Impairment and Chemoendocrine vs Endocrine Therapy in Pre- and Postmenopausal Women: A Secondary Analysis of the RxPONDER Randomized Clinical Trial.
  JAMA oncology 2026 Kang IM, Forschmiedt JK, Loch MM, Lew DL, Barlow WE, Gralow JR, Meric-Bernstam F, Albain KS, Hayes DF, Lin NU, Perez EA, Goldstein LJ, Rastogi P, Schott AF, Baehner R, Sharma P, Tripathy D, Pusztai L,…
• Combination of predicted sensitivity to endocrine therapy (SET2,3 index) and the recurrence score® in node-positive breast cancer: Independent validation in the PACS-01 trial.
  European journal of cancer (Oxford, England : 1990) 2025 Penault-Llorca F, Lusque A, Filleron T, Tran K, Du L, Baehner R, Dalenc F, Lacroix-Triki M, Bachelot T, Andre F, Boucher P, Lemonnier J, Fraser Symmans W
• HER2-low status as a distinct breast cancer subtype: myth or truth? Analysis of the WSG trials WSG-ADAPT-HR+/HER2-, WSG-PlanB, and WSG-ADAPT-TN.
  Breast cancer research : BCR 2025 Schmidt G, Gluz O, Christgen M, Reinisch M, Kümmel S, Nitz U, Braun M, Aktas B, Lüdtke-Heckenkamp K, Forstbauer H, Grischke EM, Schumacher C, Mahlberg R, Malter W, Reimer T, Nuding B, Stefek A, Wuerstlein R, Graeser M, Józwiak K, Burmeister S, Zu Eulenburg C, Lauseker M, Kolberg-Liedtke C, Prat A, Schmid P, Baehner R, Kreipe HH, Solomayer EF, Harbeck N, West German Stud y Group investigators
• Development and Validation of the RSClinN+ Tool to Predict Prognosis and Chemotherapy Benefit for Hormone Receptor-Positive, Node-Positive Breast Cancer.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2024 Pusztai L, Hoag JR, Albain KS, Barlow WE, Stemmer SM, Meisner A, Hortobagyi GN, Shak S, Rae JM, Baehner R, Sharma P, Kalinsky KM

Show all (94 more) Hide

• Molecular Characterization of HER2-Low Invasive Breast Carcinoma by Quantitative RT-PCR Using Oncotype DX Assay.
  The oncologist 2023 Lin HK, Can T, Kahn A, Flannery CA, Hoag J, Akkunuri A, Bailey H, Baehner R, Pusztai L, Rozenblit M
• Evaluation of the Sensitivity to Endocrine Therapy Index and 21-Gene Breast Recurrence Score in the SWOG S8814 Trial.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 Speers CW, Symmans WF, Barlow WE, Trevarton A, The S, Du L, Rae JM, Shak S, Baehner R, Sharma P, Pusztai L, Hortobagyi GN, Hayes DF, Albain KS, Godwin A, Thompson A
• ASO Visual Abstract: The 21-Gene Recurrence Score in Clinically High Risk Lobular and Ductal Breast Cancer-A National Cancer Database Study.
  Annals of surgical oncology 2022 Abel MK, Shui AM, Chien AJ, Rugo HS, Melisko M, Baehner F, Mukhtar RA
• Population-based estimate for the correlation of the Oncotype Dx Breast Recurrence Score® result and Ki-67 IHC MIB-1 pharmDx in HR+, HER2-, node-positive early breast cancer.
  Breast cancer research : BCR 2022 Crager M, Wijayawardana SR, Gruver AM, Blacklock A, Russell C, Baehner FL, Sapunar F
• The 21-Gene Recurrence Score in Clinically High-Risk Lobular and Ductal Breast Cancer: A National Cancer Database Study.
  Annals of surgical oncology 2022 Abel MK, Shui AM, Chien AJ, Rugo HS, Melisko M, Baehner F, Mukhtar RA
• Patient-specific meta-analysis of 12-gene colon cancer recurrence score validation studies for recurrence risk assessment after surgery with or without 5FU and oxaliplatin.
  Journal of gastrointestinal oncology 2022 Yothers G, Venook AP, Oki E, Niedzwiecki D, Lin Y, Crager MR, Chao C, Baehner FL, Wolmark N, Yoshino T
• Validating the association of adverse pathology with distant metastasis and prostate cancer mortality 20-years after radical prostatectomy.
  Urologic oncology 2021 Brooks MA, Thomas L, Magi-Galluzzi C, Li J, Crager MR, Lu R, Baehner FL, Abran J, Aboushwareb T, Klein EA
• The run-in phase of the prospective WSG-ADAPT HR+/HER2- trial demonstrates the feasibility of a study design combining static and dynamic biomarker assessments for individualized therapy in early breast cancer.
  Therapeutic advances in medical oncology 2020 Nitz U, Gluz O, Kreipe HH, Christgen M, Kuemmel S, Baehner FL, Shak S, Aktas B, Braun M, Lüdtke-Heckenkamp K, Forstbauer H, Grischke EM, Nuding B, Darsow M, Schumacher C, Krauss K, Malter W, Thill M, …
• A Comparison of Predicted Ipsilateral Tumor Recurrence Risks in Patients With Ductal Carcinoma in Situ of the Breast After Breast-Conserving Surgery by Breast Radiation Oncologists, the Van Nuys Prognostic Index, the Memorial Sloan Kettering Cancer Center DCIS Nomogram, and the 12-Gene DCIS Score Assay.
  Advances in radiation oncology 2020 Lei RY, Carter DL, Antell AG, Nowels MA, Tole SP, Bennett JP, Turner M, Baehner FL, Leonard CE
• Molecular Drivers of Oncotype DX, Prosigna, EndoPredict, and the Breast Cancer Index: A TransATAC Study.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020 Buus R, Sestak I, Kronenwett R, Ferree S, Schnabel CA, Baehner FL, Mallon EA, Cuzick J, Dowsett M
• Differential impact of prognostic parameters in hormone receptor-positive lobular breast cancer.
  Cancer 2020 Christgen M, Gluz O, Harbeck N, Kates RE, Raap M, Christgen H, Clemens M, Malter W, Nuding B, Aktas B, Kuemmel S, Reimer T, Stefek A, Krabisch P, Just M, Augustin D, Graeser M, Baehner F, Wuerstlein R…
• Molecular characterization of breast cancer needle core biopsy specimens by the 21-gene Breast Recurrence Score test.
  Journal of surgical oncology 2020 Jakubowski DM, Bailey H, Abran J, Blacklock A, Ciau N, Mies C, Tan V, Young R, Lau A, Baehner FL
• Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer.
  JAMA oncology 2020 Woodward WA, Barlow WE, Jagsi R, Buchholz TA, Shak S, Baehner F, Whelan TJ, Davidson NE, Ingle JN, King TA, Ravdin PM, Osborne CK, Tripathy D, Livingston RB, Gralow JR, Hortobagyi GN, Hayes DF, Albain…
• Persistence of Antibodies to 2 Virus-Like Particle Norovirus Vaccine Candidate Formulations in Healthy Adults: 1-Year Follow-up With Memory Probe Vaccination.
  The Journal of infectious diseases 2019 Atmar RL, Baehner F, Cramer JP, Lloyd E, Sherwood J, Borkowski A, Mendelman PM, NOR-201 Study Group
• Genomic comparison of paired primary breast carcinomas and lymph node macrometastases using the Oncotype DX Breast Recurrence Score® test.
  Breast cancer research and treatment 2019 Boolbol SK, Harshan M, Chadha M, Kirstein L, Cohen JM, Klein P, Anderson J, Davison D, Jakubowski DM, Baehner FL, Malamud S
• Accurate Estrogen Receptor Quantification in Patients with Negative and Low-Positive Estrogen-Receptor-Expressing Breast Tumors: Sub-Analyses of Data from Two Clinical Studies.
  Advances in therapy 2019 Dixon JM, Cameron DA, Arthur LM, Axelrod DM, Renshaw L, Thomas JS, Turnbull A, Young O, Loman CA, Jakubowski D, Baehner FL, Singh B
• An Exploratory Study of the Salivary Immunoglobulin A Responses to 1 Dose of a Norovirus Virus-Like Particle Candidate Vaccine in Healthy Adults.
  The Journal of infectious diseases 2019 Atmar RL, Cramer JP, Baehner F, Han C, Borkowski A, Mendelman PM
• 21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancer.
  NPJ breast cancer 2018 Geyer CE, Tang G, Mamounas EP, Rastogi P, Paik S, Shak S, Baehner FL, Crager M, Wickerham DL, Costantino JP, Wolmark N
• Erratum: Author Correction: Breast-cancer-specific mortality in patients treated based on the 21-gene assay: a SEER population-based study.
  NPJ breast cancer 2018 Petkov VI, Miller DP, Howlader N, Gliner N, Howe W, Schussler N, Cronin K, Baehner FL, Cress R, Deapen D, Glaser SL, Hernandez BY, Lynch CF, Mueller L, Schwartz AG, Schwartz SM, Stroup A, Sweeney C, …
• The 21-gene Recurrence Score® assay predicts distant recurrence in lymph node-positive, hormone receptor-positive, breast cancer patients treated with adjuvant sequential epirubicin- and docetaxel-based or epirubicin-based chemotherapy (PACS-01 trial).
  BMC cancer 2018 Penault-Llorca F, Filleron T, Asselain B, Baehner FL, Fumoleau P, Lacroix-Triki M, Anderson JM, Yoshizawa C, Cherbavaz DB, Shak S, Roca L, Sagan C, Lemonnier J, Martin AL, Roché H
• Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
  JAMA oncology 2018 Sestak I, Buus R, Cuzick J, Dubsky P, Kronenwett R, Denkert C, Ferree S, Sgroi D, Schnabel C, Baehner FL, Mallon E, Dowsett M
• Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies.
  Breast cancer research and treatment 2018 Rakovitch E, Gray R, Baehner FL, Sutradhar R, Crager M, Gu S, Nofech-Mozes S, Badve SS, Hanna W, Hughes LL, Wood WC, Davidson NE, Paszat L, Shak S, Sparano JA, Solin LJ
• 21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: results from NSABP B-28/NRG Oncology.
  Breast cancer research and treatment 2017 Mamounas EP, Tang G, Paik S, Baehner FL, Liu Q, Jeong JH, Kim SR, Butler SM, Jamshidian F, Cherbavaz DB, Sing AP, Shak S, Julian TB, Lembersky BC, Lawrence Wickerham D, Costantino JP, Wolmark N
• Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ.
  Journal of the National Cancer Institute 2017 Rakovitch E, Nofech-Mozes S, Hanna W, Sutradhar R, Baehner FL, Miller DP, Fong C, Gu S, Tuck A, Sengupta S, Elavathil L, Jani PA, Bonin M, Chang MC, Slodkowska E, Anderson JM, Cherbavaz DB, Shak S, …
• 21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy.
  Journal of the National Cancer Institute 2017 Mamounas EP, Liu Q, Paik S, Baehner FL, Tang G, Jeong JH, Kim SR, Butler SM, Jamshidian F, Cherbavaz DB, Sing AP, Shak S, Julian TB, Lembersky BC, Wickerham DL, Costantino JP, Wolmark N
• Intrinsic Subtype and Therapeutic Response Among HER2-Positive Breaty st Tumors from the NCCTG (Alliance) N9831 Trial.
  Journal of the National Cancer Institute 2016 Perez EA, Ballman KV, Mashadi-Hossein A, Tenner KS, Kachergus JM, Norton N, Necela BM, Carr JM, Ferree S, Perou CM, Baehner F, Cheang MC, Thompson EA
• Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast.
  Breast cancer research and treatment 2016 Campbell MJ, Baehner F, O'Meara T, Ojukwu E, Han B, Mukhtar R, Tandon V, Endicott M, Zhu Z, Wong J, Krings G, Au A, Gray JW, Esserman L
• The analytical validation of the Oncotype DX Recurrence Score assay.
  Ecancermedicalscience 2016 Baehner FL
• The Novel Application of Genomic Profiling Assays to Shorten Inactive Status for Potential Kidney Transplant Recipients With Breast Cancer.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2016 Mukhtar RA, Piper ML, Freise C, Van't Veer LJ, Baehner FL, Esserman LJ
• Retrospective analysis of molecular scores for the prediction of distant recurrence according to baseline risk factors.
  Breast cancer research and treatment 2016 Sestak I, Dowsett M, Ferree S, Baehner FL, Cuzick J
• Rapid Responses to 2 Virus-Like Particle Norovirus Vaccine Candidate Formulations in Healthy Adults: A Randomized Controlled Trial.
  The Journal of infectious diseases 2016 Atmar RL, Baehner F, Cramer JP, Song E, Borkowski A, Mendelman PM, NOR-201 Study Group
• Breast-cancer-specific mortality in patients treated based on the 21-gene assay: a SEER population-based study.
  NPJ breast cancer 2016 Petkov VI, Miller DP, Howlader N, Gliner N, Howe W, Schussler N, Cronin K, Baehner FL, Cress R, Deapen D, Glaser SL, Hernandez BY, Lynch CF, Mueller L, Schwartz AG, Schwartz SM, Stroup A, Sweeney C, …
• Prognostic Impact of the Combination of Recurrence Score and Quantitative Estrogen Receptor Expression (ESR1) on Predicting Late Distant Recurrence Risk in Estrogen Receptor-Positive Breast Cancer After 5 Years of Tamoxifen: Results From NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-28 and B-14.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Wolmark N, Mamounas EP, Baehner FL, Butler SM, Tang G, Jamshidian F, Sing AP, Shak S, Paik S
• Reply to C. Shah et al.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Solin LJ, Gray R, Hughes LL, Wood WC, Lowen MA, Badve SS, Baehner FL, Ingle JN, Perez EA, Recht A, Sparano JA, Davidson NE
• Association of Stromal Tumor-Infiltrating Lymphocytes With Recurrence-Free Survival in the N9831 Adjuvant Trial in Patients With Early-Stage HER2-Positive Breast Cancer.
  JAMA oncology 2016 Perez EA, Ballman KV, Tenner KS, Thompson EA, Badve SS, Bailey H, Baehner FL
• A Prospective Comparison of the 21-Gene Recurrence Score and the PAM50-Based Prosigna in Estrogen Receptor-Positive Early-Stage Breast Cancer.
  Advances in therapy 2015 Alvarado MD, Prasad C, Rothney M, Cherbavaz DB, Sing AP, Baehner FL, Svedman C, Markopoulos CJ
• The relationship between quantitative human epidermal growth factor receptor 2 gene expression by the 21-gene reverse transcriptase polymerase chain reaction assay and adjuvant trastuzumab benefit in Alliance N9831.
  Breast cancer research : BCR 2015 Perez EA, Baehner FL, Butler SM, Thompson EA, Dueck AC, Jamshidian F, Cherbavaz D, Yoshizawa C, Shak S, Kaufman PA, Davidson NE, Gralow J, Asmann YW, Ballman KV
• Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015 Solin LJ, Gray R, Hughes LL, Wood WC, Lowen MA, Badve SS, Baehner FL, Ingle JN, Perez EA, Recht A, Sparano JA, Davidson NE
• SAFETY OF A CRM197-CONJUGATED HAEMOPHILUS INFLUENZAE TYPE B VACCINE IN KOREAN CHILDREN.
  The Southeast Asian journal of tropical medicine and public health 2015 Song H, Bock H, Guadagno A, Costantini M, Baehner F, Kim YH, Ahn SI, Son KH, Yim DS
• A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone.
  Breast cancer research and treatment 2015 Rakovitch E, Nofech-Mozes S, Hanna W, Baehner FL, Saskin R, Butler SM, Tuck A, Sengupta S, Elavathil L, Jani PA, Bonin M, Chang MC, Robertson SJ, Slodkowska E, Fong C, Anderson JM, Jamshidian F, …
• Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial.
  PLoS medicine 2015 Lindesmith LC, Ferris MT, Mullan CW, Ferreira J, Debbink K, Swanstrom J, Richardson C, Goodwin RR, Baehner F, Mendelman PM, Bargatze RF, Baric RS
• The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.
  Annals of oncology : official journal of the European Society for Medical Oncology 2014 Salgado R, Denkert C, Demaria S, Sirtaine N, Klauschen F, Pruneri G, Wienert S, Van den Eynden G, Baehner FL, Penault-Llorca F, Perez EA, Thompson EA, Symmans WF, Richardson AL, Brock J, Criscitiello …
• A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.
  European urology 2014 Klein EA, Cooperberg MR, Magi-Galluzzi C, Simko JP, Falzarano SM, Maddala T, Chan JM, Li J, Cowan JE, Tsiatis AC, Cherbavaz DB, Pelham RJ, Tenggara-Hunter I, Baehner FL, Knezevic D, Febbo PG, Shak S, …
• The prognostic implications of macrophages expressing proliferating cell nuclear antigen in breast cancer depend on immune context.
  PloS one 2013 Campbell MJ, Wolf D, Mukhtar RA, Tandon V, Yau C, Au A, Baehner F, van't Veer L, Berry D, Esserman LJ
• Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry.
  The American journal of surgical pathology 2013 Dabbs DJ, Schnitt SJ, Geyer FC, Weigelt B, Baehner FL, Decker T, Eusebi V, Fox SB, Ichihara S, Lakhani SR, Palacios J, Rakha E, Richardson AL, Schmitt FC, Tan PH, Tse GM, Vincent-Salomon A, Ellis IO, …
• A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.
  Journal of the National Cancer Institute 2013 Solin LJ, Gray R, Baehner FL, Butler SM, Hughes LL, Yoshizawa C, Cherbavaz DB, Shak S, Page DL, Sledge GW, Davidson NE, Ingle JN, Perez EA, Wood WC, Sparano JA, Badve S
• MR imaging features of gadofluorine-labeled matrix-associated stem cell implants in cartilage defects.
  PloS one 2012 Nejadnik H, Henning TD, Do T, Sutton EJ, Baehner F, Horvai A, Sennino B, McDonald D, Meier R, Misselwitz B, Link TM, Daldrup-Link HE
• Xenografts faithfully recapitulate breast cancer-specific gene expression patterns of parent primary breast tumors.
  Breast cancer research and treatment 2012 Petrillo LA, Wolf DM, Kapoun AM, Wang NJ, Barczak A, Xiao Y, Korkaya H, Baehner F, Lewicki J, Wicha M, Park JW, Spellman PT, Gray JW, Van't Veer L, Esserman LJ
• Elevated levels of proliferating and recently migrated tumor-associated macrophages confer increased aggressiveness and worse outcomes in breast cancer.
  Annals of surgical oncology 2012 Mukhtar RA, Moore AP, Tandon VJ, Nseyo O, Twomey P, Adisa CA, Eleweke N, Au A, Baehner FL, Moore DH, McGrath MS, Olopade OI, Gray JW, Campbell MJ, Esserman LJ
• Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 study.
  Breast cancer research and treatment 2012 Solin LJ, Gray R, Goldstein LJ, Recht A, Baehner FL, Shak S, Badve S, Perez EA, Shulman LN, Martino S, Davidson NE, Sledge GW, Sparano JA
• Accurate assessment of human epidermal growth factor receptor 2.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Baehner FL, Yoshizawa C, Shak S
• Morphometic analysis of TCGA glioblastoma multiforme.
  BMC bioinformatics 2011 Chang H, Fontenay GV, Han J, Cong G, Baehner FL, Gray JW, Spellman PT, Parvin B
• Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Gray RG, Quirke P, Handley K, Lopatin M, Magill L, Baehner FL, Beaumont C, Clark-Langone KM, Yoshizawa CN, Lee M, Watson D, Shak S, Kerr DJ
• The impact of primary melanoma thickness and microscopic tumor burden in sentinel lymph nodes on melanoma patient survival.
  Annals of surgical oncology 2011 Baehner FL, Li R, Jenkins T, Hwang J, Kashani-Sabet M, Allen RE, Leong SP
• Estrogen receptor (ESR1) mRNA expression and benefit from tamoxifen in the treatment and prevention of estrogen receptor-positive breast cancer.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Kim C, Tang G, Pogue-Geile KL, Costantino JP, Baehner FL, Baker J, Cronin MT, Watson D, Shak S, Bohn OL, Fumagalli D, Taniyama Y, Lee A, Reilly ML, Vogel VG, McCaskill-Stevens W, Ford LG, Geyer CE, …
• Relationship between quantitative GRB7 RNA expression and recurrence after adjuvant anthracycline chemotherapy in triple-negative breast cancer.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Sparano JA, Goldstein LJ, Childs BH, Shak S, Brassard D, Badve S, Baehner FL, Bugarini R, Rowley S, Perez EA, Shulman LN, Martino S, Davidson NE, Kenny PA, Sledge GW, Gray R
• Elevated PCNA+ tumor-associated macrophages in breast cancer are associated with early recurrence and non-Caucasian ethnicity.
  Breast cancer research and treatment 2011 Mukhtar RA, Moore AP, Nseyo O, Baehner FL, Au A, Moore DH, Twomey P, Campbell MJ, Esserman LJ
• Biologic markers determine both the risk and the timing of recurrence in breast cancer.
  Breast cancer research and treatment 2011 Esserman LJ, Moore DH, Tsing PJ, Chu PW, Yau C, Ozanne E, Chung RE, Tandon VJ, Park JW, Baehner FL, Kreps S, Tutt AN, Gillett CE, Benz CC
• Genomic signatures of cancer: basis for individualized risk assessment, selective staging and therapy.
  Journal of surgical oncology 2011 Baehner FL, Lee M, Demeure MJ, Bussey KJ, Kiefer JA, Barrett MT
• Rt-PCR gene expression profiling of RNA from paraffin-embedded tissues prepared using a range of different fixatives and conditions.
  Methods in molecular biology (Clifton, N.J.) 2011 Liu ML, Jeong J, Ambannavar R, Millward C, Baehner F, Sangli C, Dutta D, Pho M, Nguyen A, Cronin MT
• Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists.
  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2010 Badve S, Dabbs DJ, Schnitt SJ, Baehner FL, Decker T, Eusebi V, Fox SB, Ichihara S, Jacquemier J, Lakhani SR, Palacios J, Rakha EA, Richardson AL, Schmitt FC, Tan PH, Tse GM, Weigelt B, Ellis IO, Reis-…
• In vivo magnetic resonance imaging and optical imaging comparison of viable and nonviable mesenchymal stem cells with a bifunctional label.
  Molecular imaging 2010 Sutton EJ, Henning TD, Boddington S, Demos S, Krug C, Meier R, Kornak J, Zhao S, Baehner R, Sharifi S, Daldrup-Link H
• Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome.
  Breast cancer research and treatment 2010 Campbell MJ, Tonlaar NY, Garwood ER, Huo D, Moore DH, Khramtsov AI, Au A, Baehner F, Chen Y, Malaka DO, Lin A, Adeyanju OO, Li S, Gong C, McGrath M, Olopade OI, Esserman LJ
• Human epidermal growth factor receptor 2 assessment in a case-control study: comparison of fluorescence in situ hybridization and quantitative reverse transcription polymerase chain reaction performed by central laboratories.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Baehner FL, Achacoso N, Maddala T, Shak S, Quesenberry CP, Goldstein LC, Gown AM, Habel LA
• Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorin.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 O'Connell MJ, Lavery I, Yothers G, Paik S, Clark-Langone KM, Lopatin M, Watson D, Baehner FL, Shak S, Baker J, Cowens JW, Wolmark N
• Breast cancer prognostic classification in the molecular era: the role of histological grade.
  Breast cancer research : BCR 2010 Rakha EA, Reis-Filho JS, Baehner F, Dabbs DJ, Decker T, Eusebi V, Fox SB, Ichihara S, Jacquemier J, Lakhani SR, Palacios J, Richardson AL, Schnitt SJ, Schmitt FC, Tan PH, Tse GM, Badve S, Ellis IO
• Feasibility of using tissue microarray cores of paraffin-embedded breast cancer tissue for measurement of gene expression: a proof-of-concept study.
  Journal of clinical pathology 2010 Drury S, Salter J, Baehner FL, Shak S, Dowsett M
• Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Dowsett M, Cuzick J, Wale C, Forbes J, Mallon EA, Salter J, Quinn E, Dunbier A, Baum M, Buzdar A, Howell A, Bugarini R, Baehner FL, Shak S
• Molecular predictors of 3D morphogenesis by breast cancer cell lines in 3D culture.
  PLoS computational biology 2010 Han J, Chang H, Giricz O, Lee GY, Baehner FL, Gray JW, Bissell MJ, Kenny PA, Parvin B
• Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer.
  Breast cancer research and treatment 2010 Garwood ER, Kumar AS, Baehner FL, Moore DH, Au A, Hylton N, Flowers CI, Garber J, Lesnikoski BA, Hwang ES, Olopade O, Port ER, Campbell M, Esserman LJ
• The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade.
  The Journal of pathology 2010 Weigelt B, Baehner FL, Reis-Filho JS
• An optical imaging method to monitor stem cell migration in a model of immune-mediated arthritis.
  Optics express 2009 Sutton EJ, Boddington SE, Nedopil AJ, Henning TD, Demos SG, Baehner R, Sennino B, Lu Y, Daldrup-Link HE
• Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Sparano JA, Goldstein LJ, Childs BH, Shak S, Brassard D, Badve S, Baehner FL, Bugarini R, Rowley S, Perez E, Shulman LN, Martino S, Davidson NE, Sledge GW, Gray R
• Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial.
  The Lancet. Oncology 2009 Albain KS, Barlow WE, Shak S, Hortobagyi GN, Livingston RB, Yeh IT, Ravdin P, Bugarini R, Baehner FL, Davidson NE, Sledge GW, Winer EP, Hudis C, Ingle JN, Perez EA, Pritchard KI, Shepherd L, Gralow JR…
• A multimarker prognostic assay for primary cutaneous melanoma.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Kashani-Sabet M, Venna S, Nosrati M, Rangel J, Sucker A, Egberts F, Baehner FL, Simko J, Leong SP, Haqq C, Hauschild A, Schadendorf D, Miller JR, Sagebiel RW
• The transmembrane src substrate Trask is an epithelial protein that signals during anchorage deprivation.
  The American journal of pathology 2009 Spassov DS, Baehner FL, Wong CH, McDonough S, Moasser MM
• Phosphorylation of the SRC epithelial substrate Trask is tightly regulated in normal epithelia but widespread in many human epithelial cancers.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Wong CH, Baehner FL, Spassov DS, Ahuja D, Wang D, Hann B, Blair J, Shokat K, Welm AL, Moasser MM
• Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistry.
  Applied immunohistochemistry & molecular morphology : AIMM 2008 Yaziji H, Taylor CR, Goldstein NS, Dabbs DJ, Hammond EH, Hewlett B, Floyd AD, Barry TS, Martin AW, Badve S, Baehner F, Cartun RW, Eisen RN, Swanson PE, Hewitt SM, Vyberg M, Hicks DG, Members of the …
• Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008 Goldstein LJ, Gray R, Badve S, Childs BH, Yoshizawa C, Rowley S, Shak S, Baehner FL, Ravdin PM, Davidson NE, Sledge GW, Perez EA, Shulman LN, Martino S, Sparano JA
• Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008 Badve SS, Baehner FL, Gray RP, Childs BH, Maddala T, Liu ML, Rowley SC, Shak S, Perez EA, Perez ED, Shulman LJ, Martino S, Davidson NE, Sledge GW, Goldstein LJ, Sparano JA
• Gene expression patterns in formalin-fixed, paraffin-embedded core biopsies predict docetaxel chemosensitivity in breast cancer patients.
  Breast cancer research and treatment 2007 Chang JC, Makris A, Gutierrez MC, Hilsenbeck SG, Hackett JR, Jeong J, Liu ML, Baker J, Clark-Langone K, Baehner FL, Sexton K, Mohsin S, Gray T, Alvarez L, Chamness GC, Osborne CK, Shak S
• MR imaging of antigen-induced arthritis with a new, folate receptor-targeted contrast agent.
  Contrast media & molecular imaging 2007 Saborowski O, Simon GH, Raatschen HJ, Wendland MF, Fu Y, Henning T, Baehner R, Corot C, Chen MH, Daldrup-Link HE
• Stathmin is overexpressed in malignant mesothelioma.
  Anticancer research 2007 Kim JY, Harvard C, You L, Xu Z, Kuchenbecker K, Baehner R, Jablons D
• A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.
  Cancer cell 2006 Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F, Speed T, Spellman PT, DeVries S, Lapuk A, Wang NJ, Kuo WL, Stilwell JL, Pinkel D, Albertson DG, Waldman FM…
• Predicting response to primary chemotherapy: gene expression profiling of paraffin-embedded core biopsy tissue.
  Breast cancer research and treatment 2006 Mina L, Soule SE, Badve S, Baehner FL, Baker J, Cronin M, Watson D, Liu ML, Sledge GW, Shak S, Miller KD
• Prognostic significance of nuclear receptor coactivator-3 overexpression in primary cutaneous melanoma.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006 Rangel J, Torabian S, Shaikh L, Nosrati M, Baehner FL, Haqq C, Leong SP, Miller JR, Sagebiel RW, Kashani-Sabet M
• Breast cancer growth prevention by statins.
  Cancer research 2006 Campbell MJ, Esserman LJ, Zhou Y, Shoemaker M, Lobo M, Borman E, Baehner F, Kumar AS, Adduci K, Marx C, Petricoin EF, Liotta LA, Winters M, Benz S, Benz CC
• Genes and pathways downstream of telomerase in melanoma metastasis.
  Proceedings of the National Academy of Sciences of the United States of America 2006 Bagheri S, Nosrati M, Li S, Fong S, Torabian S, Rangel J, Moore DH, Federman S, Laposa RR, Baehner FL, Sagebiel RW, Cleaver JE, Haqq C, Debs RJ, Blackburn EH, Kashani-Sabet M
• IgA nephropathy in two adolescent sisters heterozygous for Fabry disease.
  Pediatric nephrology (Berlin, Germany) 2006 Whybra C, Schwarting A, Kriegsmann J, Gal A, Mengel E, Kampmann C, Baehner F, Schaefer E, Beck M
• Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006 Paik S, Tang G, Shak S, Kim C, Baker J, Kim W, Cronin M, Baehner FL, Watson D, Bryant J, Costantino JP, Geyer CE, Wickerham DL, Wolmark N
• Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo.
  Cancer research 2006 Park CC, Zhang H, Pallavicini M, Gray JW, Baehner F, Park CJ, Bissell MJ
• Fine needle aspiration cytology of adult perineal rhabdomyosarcoma: a case report.
  Acta cytologica 2006 Meng MV, Grossfeld GD, Sudilovsky D, Baehner FL
• Metastatic balloon cell melanoma: a case report.
  Acta cytologica 2005 Baehner FL, Ng B, Sudilovsky D
• Cumulative incidence rates of the mucopolysaccharidoses in Germany.
  Journal of inherited metabolic disease 2005 Baehner F, Schmiedeskamp C, Krummenauer F, Miebach E, Bajbouj M, Whybra C, Kohlschütter A, Kampmann C, Beck M